Artigos de revistas sobre o tema "Lung and breast/ovarian cancer"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Lung and breast/ovarian cancer".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Prat, Aleix, Barbara Adamo, Cheng Fan, Maria Vidal, Patricia Galvan, Enriqueta Felip, Jose Maria Del Campo, Josep Tabernero e Javier Cortes. "Molecular identification of basal-like breast cancer through genomic analyses across five cancer types." Journal of Clinical Oncology 31, n.º 15_suppl (20 de maio de 2013): 1011. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1011.
Texto completo da fonteAchariyapota, Vuthinun, Tuenjai Chuangsuwanich e Mongkol Benjapibal. "Inflammatory Breast Cancer from Metastatic Ovarian Cancer". Case Reports in Obstetrics and Gynecology 2016 (2016): 1–3. http://dx.doi.org/10.1155/2016/3476143.
Texto completo da fonteR., Abhirup H., Priyanka Kenchetty e Aishwarya K. Chidananda. "Breast ovarian cancer syndrome". International Surgery Journal 8, n.º 8 (28 de julho de 2021): 2454. http://dx.doi.org/10.18203/2349-2902.isj20213144.
Texto completo da fonteAbu-Tineh, Mohammad, Hind Elmalik e Mohamed A. Yassin. "Metastatic Ovarian Cancer Presenting as Inflammatory Breast Cancer: A Case Report". Case Reports in Oncology 13, n.º 2 (28 de julho de 2020): 867–74. http://dx.doi.org/10.1159/000508358.
Texto completo da fonteBacalbasa, Nicolae, Irina Balescu, Claudia Stoica, Cristina Martac, Valentin Varlas, Andrei Voichitoiu, Lucian Pop, Sorin Petrea, Mihaela Vilcu e Iulian Brezean. "Breast metastases from ovarian cancer". Romanian Medical Journal 69, S4 (20 de junho de 2022): 14–16. http://dx.doi.org/10.37897/rmj.2022.s4.3.
Texto completo da fonteArora, Nimisha, Aline Talhouk, Jessica N. McAlpine, Michael R. Law e Gillian E. Hanley. "Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada". International Journal of Gynecologic Cancer 29, n.º 3 (21 de dezembro de 2018): 593–98. http://dx.doi.org/10.1136/ijgc-2018-000040.
Texto completo da fonteHaan, David, Anna Bergamaschi, Yuhong Ning, William Gibb, Michael Kesling, Adriana Pitea, Maryam Nabiyouni et al. "Genome-wide 5hmC profiles to enable cancer detection and tissue of origin classification in breast, colorectal, lung, ovarian, and pancreatic cancers." Journal of Clinical Oncology 39, n.º 15_suppl (20 de maio de 2021): 3044. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.3044.
Texto completo da fonteTkaczuk, Katherine R., Paula Rosenblatt, Ranee Mehra, Katherine A. Scilla, Nancy Tait, Katerra Caple, Binbin Yue e Ginette Serrero. "Abstract CT240: On-going phase 1A clinical trial for AG01 an first-in-class anti-progranulin (GP88) monoclonal antibody in patients with advanced malignancies". Cancer Research 83, n.º 8_Supplement (14 de abril de 2023): CT240. http://dx.doi.org/10.1158/1538-7445.am2023-ct240.
Texto completo da fonteRoland, Adjoby Cassou, Kouamé Arthur Didier, Koffi Achille, Kakou Charles, Konan Joachim, Andriamandimbison Zoly, Ahounkeng Patrick e Nshimirimana Eric. "Metastatic ovarian tumor of a lung cancer at the hospital center of Chauny (France): a case report". International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6, n.º 10 (23 de setembro de 2017): 4682. http://dx.doi.org/10.18203/2320-1770.ijrcog20174464.
Texto completo da fonteYurkovetsky, Zoya, Steven Skates, Aleksey Lomakin, Brian Nolen, Trenton Pulsipher, Francesmary Modugno, Jeffrey Marks et al. "Development of a Multimarker Assay for Early Detection of Ovarian Cancer". Journal of Clinical Oncology 28, n.º 13 (1 de maio de 2010): 2159–66. http://dx.doi.org/10.1200/jco.2008.19.2484.
Texto completo da fonteTkaczuk, Katherine, Paula Rosenblatt, Ranee Mehra, Katherine Scilla, Nancy Tait, Binbin Yue e Ginette Serrero. "Abstract PO5-18-06: On-going phase 1A clinical trial of A01, a chimerized monoclonal antibody to Progranulin/Glycoprotein 88 (GP88) in patients with advanced malignancy". Cancer Research 84, n.º 9_Supplement (2 de maio de 2024): PO5–18–06—PO5–18–06. http://dx.doi.org/10.1158/1538-7445.sabcs23-po5-18-06.
Texto completo da fonteCovic, Lidija, e Athan Kuliopulos. "Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach". International Journal of Molecular Sciences 19, n.º 8 (31 de julho de 2018): 2237. http://dx.doi.org/10.3390/ijms19082237.
Texto completo da fonteO'Shannessy, Daniel J., Darren W. Davis, Kenna Anderes e Elizabeth B. Somers. "Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream® for Detecting (or Monitoring) the Expression of Folate Receptor Alpha". Biomarker Insights 11 (janeiro de 2016): BMI.S35075. http://dx.doi.org/10.4137/bmi.s35075.
Texto completo da fonteSaad, Hebatallah M., Ghada F. Tourky, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ahmed M. Khattab, Sohaila A. Elmasry, Abdulrahman A. Alsayegh et al. "The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity". Diagnostics 12, n.º 12 (29 de novembro de 2022): 2985. http://dx.doi.org/10.3390/diagnostics12122985.
Texto completo da fonteBodogai, Monica, Purevdorj Olkhanud, Yrina Rochman, Enkhzol Malchinkhuu, Katarzyna Wejksza, Ronald Gress, Charles Hesdorffer, Warren Leonard e Arya Biragyn. "Thymic stromal lymphopoietin mediates breast cancer progression and metastasis (48.9)". Journal of Immunology 186, n.º 1_Supplement (1 de abril de 2011): 48.9. http://dx.doi.org/10.4049/jimmunol.186.supp.48.9.
Texto completo da fonteKarim, Md Adnan, Abdus Samad, Utpal Kumar Adhikari, Md Ashraful Kader, Md Masnoon Kabir, Md Aminul Islam e Md Nazmul Hasan. "A Multi-Omics Analysis of Bone Morphogenetic Protein 5 (BMP5) mRNA Expression and Clinical Prognostic Outcomes in Different Cancers Using Bioinformatics Approaches". Biomedicines 8, n.º 2 (21 de janeiro de 2020): 19. http://dx.doi.org/10.3390/biomedicines8020019.
Texto completo da fontePinheiro, Céline, Rui M. Reis, Sara Ricardo, Adhemar Longatto-Filho, Fernando Schmitt e Fátima Baltazar. "Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44". Journal of Biomedicine and Biotechnology 2010 (2010): 1–7. http://dx.doi.org/10.1155/2010/427694.
Texto completo da fonteWeiss, Jessica M., Muhammad Danyal Ahsan, Emily M. Webster, Sarah R. Levi, Murtaza Qazi, Benedict Harvey, Evelyn Cantillo et al. "Hereditary breast and ovarian cancer syndrome: A misnomer?" Journal of Clinical Oncology 41, n.º 16_suppl (1 de junho de 2023): 10594. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.10594.
Texto completo da fonteArason, Agnarsson, Johannesdottir, Johannsson, Hilmarsdottir, Reynisdottir e Barkardottir. "The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability". Genes 10, n.º 11 (1 de novembro de 2019): 882. http://dx.doi.org/10.3390/genes10110882.
Texto completo da fonteErickson-Miller, Connie L., Jennifer Kirchner, Kodandaram Pillarisetti, Lone Ottesen, Yasser Mostafa Kamel, Yuan Liu, Anne-Marie Martin e Conrad Messam. "Eltrombopag Decreases Proliferation of Ovarian, Lung and Breast Tumor Cell Lines." Blood 114, n.º 22 (20 de novembro de 2009): 2409. http://dx.doi.org/10.1182/blood.v114.22.2409.2409.
Texto completo da fonteBenti, Senyi, Purushottam B. Tiwari, Dustin W. Goodlett, Leily Daneshian, Grant B. Kern, Mark D. Smith, Aykut Uren, Maksymilian Chruszcz, Linda S. Shimizu e Geeta Upadhyay. "Small Molecule Binds with Lymphocyte Antigen 6K to Induce Cancer Cell Death". Cancers 12, n.º 2 (22 de fevereiro de 2020): 509. http://dx.doi.org/10.3390/cancers12020509.
Texto completo da fonteCalaf, Gloria M., Leodan A. Crispin, Juan P. Muñoz, Francisco Aguayo e Tammy C. Bleak. "Muscarinic Receptors Associated with Cancer". Cancers 14, n.º 9 (7 de maio de 2022): 2322. http://dx.doi.org/10.3390/cancers14092322.
Texto completo da fonteFerreira, Thamara, Thais Ferreira Bomfim-Palma, Isabelle Joyce de Lima Silva-Fernandes, Gabriela Espirito Santo Felix, Inacelli Queiroz De Souza Caires, Leandro Apolinário Silva, Luciana Garcia Landeiro et al. "PALB2 mutations in Brazilian patients from North-Northeast regions." Journal of Clinical Oncology 38, n.º 15_suppl (20 de maio de 2020): e13670-e13670. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13670.
Texto completo da fonteDUPONT, J., C. AGHAJANIAN, P. SABBATINI e D. R. SPRIGGS. "New agents for the treatment of ovarian cancer: the next generation". International Journal of Gynecologic Cancer 15, Suppl 3 (novembro de 2005): 252–57. http://dx.doi.org/10.1136/ijgc-00009577-200511001-00012.
Texto completo da fonteMuggia, Franco M. "Significant developments in ovarian, breast and lung cancer therapy". Inpharma Weekly &NA;, n.º 994 (julho de 1995): 3–5. http://dx.doi.org/10.2165/00128413-199509940-00002.
Texto completo da fonteBrown, Geoffrey. "Deregulation of All-Trans Retinoic Acid Signaling and Development in Cancer". International Journal of Molecular Sciences 24, n.º 15 (28 de julho de 2023): 12089. http://dx.doi.org/10.3390/ijms241512089.
Texto completo da fonteCole, Alexander P., Chang Lu, Marieke J. Krimphove, Julie Szymaniak, Maxine Sun, Sean A. Fletcher, Stuart R. Lipsitz et al. "Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast Cancers". Journal of the National Comprehensive Cancer Network 17, n.º 9 (setembro de 2019): 1049–58. http://dx.doi.org/10.6004/jnccn.2019.7296.
Texto completo da fonteSolomon, Benjamin Maurice, Kari G. Rabe, Susan L. Slager, Jerry D. Brewer, James R. Cerhan e Tait D. Shanafelt. "Overall and cancer-specific survival of breast, colon, and lung cancer in patients with and without chronic lymphocytic leukemia: A SEER population-based study of over 1 million patients." Journal of Clinical Oncology 30, n.º 15_suppl (20 de maio de 2012): 6571. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.6571.
Texto completo da fonteLawler, Thomas, e Shaneda Warren Andersen. "Serum 25-Hydroxyvitamin D and Cancer Risk: A Systematic Review of Mendelian Randomization Studies". Nutrients 15, n.º 2 (13 de janeiro de 2023): 422. http://dx.doi.org/10.3390/nu15020422.
Texto completo da fonteGuo, Maoni, e San Ming Wang. "The BRCAness Landscape of Cancer". Cells 11, n.º 23 (1 de dezembro de 2022): 3877. http://dx.doi.org/10.3390/cells11233877.
Texto completo da fonteCheng, En, Donghoon Lee, Rulla M. Tamimi, Susan Hankinson, Walter C. Willett, Edward L. Giovannucci, Heather Eliassen et al. "Long-term cancer survival in cohorts of U.S. health professionals." Journal of Clinical Oncology 38, n.º 15_suppl (20 de maio de 2020): 12075. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.12075.
Texto completo da fonteTourassi, Georgia, Hong-Jun Yoon, Songhua Xu e Xuesong Han. "The utility of web mining for epidemiological research: studying the association between parity and cancer risk". Journal of the American Medical Informatics Association 23, n.º 3 (27 de novembro de 2015): 588–95. http://dx.doi.org/10.1093/jamia/ocv141.
Texto completo da fonteLuo, Huiyan, Pansong Li, Wei Wei, Yong-Bin Lin, Hong Yang, Han Yang, Kong-Jia Luo et al. "High-sensitive multi-cancers early detection for 8 cancer types by cell-free DNA targeted methylation sequencing: A retrospective cohort study." Journal of Clinical Oncology 42, n.º 16_suppl (1 de junho de 2024): 3043. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3043.
Texto completo da fonteOlea-Flores, Monserrat, Juan C. Juárez-Cruz, Miriam D. Zuñiga-Eulogio, Erika Acosta, Eduardo García-Rodríguez, Ana E. Zacapala-Gomez, Miguel A. Mendoza-Catalán, Julio Ortiz-Ortiz, Carlos Ortuño-Pineda e Napoleón Navarro-Tito. "New Actors Driving the Epithelial–Mesenchymal Transition in Cancer: The Role of Leptin". Biomolecules 10, n.º 12 (15 de dezembro de 2020): 1676. http://dx.doi.org/10.3390/biom10121676.
Texto completo da fonteBacalbasa, N., A. Traistaru e I. Balescu. "OVARIAN METASTATIC TUMORS – A LITERATURE REVIEW". Romanian Medical Journal 62, n.º 2 (30 de junho de 2015): 115–18. http://dx.doi.org/10.37897/rmj.2015.2.6.
Texto completo da fonteAdeboyeje, Gboyega, Eleanor O. Caplan, Yihua Xu, Monica Chase, Sheetal Sheth, Brandon T. Suehs e Nicole Myer. "Abstract 4111: Trends in the use of broad genomic sequencing-directed therapy among Medicare patients with newly diagnosed advanced cancer in the United States from 2018-2020: A retrospective analysis from the SEQUENCE study". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 4111. http://dx.doi.org/10.1158/1538-7445.am2022-4111.
Texto completo da fonteYap, Timothy A., Arya Ashok, Jessica Stoll, Anna Ewa Schwarzbach, Kimberly L. Blackwell, Tianhong Li, Hyunseok Kang, Judy Ellen Garber e Funda Meric-Bernstam. "Rate of incidental germline findings detected by tumor-normal matched sequencing in cancer types lacking hereditary cancer testing guidelines." Journal of Clinical Oncology 39, n.º 15_suppl (20 de maio de 2021): 10582. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.10582.
Texto completo da fonteVlasenkova, Ramilia, Alsina Nurgalieva, Natalia Akberova, Mikhail Bogdanov e Ramziya Kiyamova. "Characterization of SLC34A2 as a Potential Prognostic Marker of Oncological Diseases". Biomolecules 11, n.º 12 (14 de dezembro de 2021): 1878. http://dx.doi.org/10.3390/biom11121878.
Texto completo da fonteAtta, Ihab Shafek, e Fahd Nasser AlQahtani. "Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence". Case Reports in Medicine 2016 (2016): 1–5. http://dx.doi.org/10.1155/2016/2928084.
Texto completo da fonteHeeke, Arielle Lutterman, Tabari Baker, Filipa Lynce, Michael J. Pishvaian e Claudine Isaacs. "Prevalence of homologous recombination deficiency among all tumor types." Journal of Clinical Oncology 35, n.º 15_suppl (20 de maio de 2017): 1502. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1502.
Texto completo da fonteBel’skaya, Lyudmila V., Elena A. Sarf, Alexandra I. Loginova, Dmitry M. Vyushkov e En Djun Choi. "Potential Diagnostic Value of Salivary Tumor Markers in Breast, Lung and Ovarian Cancer: A Preliminary Study". Current Issues in Molecular Biology 45, n.º 6 (10 de junho de 2023): 5084–98. http://dx.doi.org/10.3390/cimb45060323.
Texto completo da fonteChen, Lifeng, Binbing Ling, Jane Alcorn e Jian Yang. "Quantitative Analysis of the Expression of Human N-myristoyltransferase 1 (hNMT-1) in Cancers". Open Biomarkers Journal 2, n.º 1 (13 de março de 2009): 6–10. http://dx.doi.org/10.2174/1875318300902010006.
Texto completo da fonteCuriel, Tyler, Suzanne Thibodeaux, Shawna Wall, Sri Lakshmi Pandeswara, Benjamin Daniel, Justin Drerup, Kruthi Murthy, Ilona Kryczek, Weiping Zou e Brian Barnett. "Denileukin diftitox depletes regulatory T cells without clinical benefit in advanced stage epithelial ovarian carcinoma (VAC3P.945)". Journal of Immunology 192, n.º 1_Supplement (1 de maio de 2014): 73.7. http://dx.doi.org/10.4049/jimmunol.192.supp.73.7.
Texto completo da fonteDetopoulou, Paraskevi, George I. Panoutsopoulos, Marina Mantoglou, Periklis Michailidis, Ifigenia Pantazi, Spyros Papadopoulos e Andrea Paola Rojas Gil. "Relation of Mean Platelet Volume (MPV) with Cancer: A Systematic Review with a Focus on Disease Outcome on Twelve Types of Cancer". Current Oncology 30, n.º 3 (14 de março de 2023): 3391–420. http://dx.doi.org/10.3390/curroncol30030258.
Texto completo da fonteChoi, Eunji, Justin Lee, Julie T. Wu, Heather A. Wakelee, Lidia Schapira, Allison W. Kurian e Summer S. Han. "Abstract P055: Risk factors for second primary lung cancer among breast cancer survivors". Cancer Prevention Research 16, n.º 1_Supplement (1 de janeiro de 2023): P055. http://dx.doi.org/10.1158/1940-6215.precprev22-p055.
Texto completo da fonteSah, Sunil Kumar, Naval Kishor Yadav, Roshan Kurmi, Ramanuj Rauniyar, Krishan Das Manandhar e Birendra Prasad Gupta. "Pattern of Cancer in Nepal from 2003 to 2011". Nepal Journal of Biotechnology 4, n.º 1 (31 de dezembro de 2016): 54–60. http://dx.doi.org/10.3126/njb.v4i1.16348.
Texto completo da fonteLindsay, Colin R., Emily C. Shaw, Fiona Blackhall, Kevin G. Blyth, James D. Brenton, Anshuman Chaturvedi, Noel Clarke et al. "Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme". ESMO Open 3, n.º 6 (setembro de 2018): e000408. http://dx.doi.org/10.1136/esmoopen-2018-000408.
Texto completo da fonteSun, Ming-Yang, Chia-Lun Chang, Chang-Yun Lu, Szu-Yuan Wu e Jia-Qiang Zhang. "Sarcopenia as an Independent Risk Factor for Specific Cancers: A Propensity Score-Matched Asian Population-Based Cohort Study". Nutrients 14, n.º 9 (2 de maio de 2022): 1910. http://dx.doi.org/10.3390/nu14091910.
Texto completo da fonteMetzen, Marlon, Michael Bruns, Wolfgang Deppert e Udo Schumacher. "Infiltration of Immune Competent Cells into Primary Tumors and Their Surrounding Connective Tissues in Xenograft and Syngeneic Mouse Models". International Journal of Molecular Sciences 22, n.º 8 (19 de abril de 2021): 4213. http://dx.doi.org/10.3390/ijms22084213.
Texto completo da fonteKawashiri, Takehiro, Daisuke Kobayashi, Mayako Uchida, Shiori Hiromoto, Masashi Inoue, Hajime Ikeda, Mizuki Inoue e Takao Shimazoe. "Analysis of Secondary Leukemia and Myelodysplastic Syndrome After Chemotherapy for Solid Organ Tumors Using the Food and Drug Administration Adverse Event Reporting System (FAERS)". Journal of Pharmacy & Pharmaceutical Sciences 24 (11 de outubro de 2021): 499–508. http://dx.doi.org/10.18433/jpps31862.
Texto completo da fonte